Luye Pharma Group Limited - Capital/Financing Update 2014

Post Hearing Information Pack



	LUYE PHARMA GROUP LTD.

	YOU SHOULD READ THE WARNING IN THE DOCUMENT.



	Warning
	Important
	Expected Timetable
	Contents
	Summary
	Definitions
	Glossary of Technical Terms
	Forward-looking Statements
	Risk Factors
	Waivers from Compliance with the Listing Rules
	Information about this Document and the Global Offering
	Directors and Parties Involved in the Global Offering
	Corporate Information
	Industry Overview
	Regulations
	History and Development
	Business
	Financial Information
	Relationship with Controlling Shareholder
	Connected Transaction
	Share Capital
	Cornerstone Investors
	Substantial Shareholders
	Directors and Senior Management
	Future Plans and Use of Proceeds
	Underwriting
	Structure of the Global Offering
	How to Apply for Hong Kong Offer Shares
	Appendix I – Accountants’ Report
	Appendix II – Unaudited Pro Forma Financial Information
	Appendix III – Summary of the Constitution of our Company and Bermuda Companies Act
	Appendix IV – Statutory and General Information
	Appendix V – Documents Delivered to the Registrar of Companies in Hong Kong and Available for Inspection
	Appendix VI – Intellectual Property Rights

AI assistant